Borderline ovarian tumours: Retrospective analysis of twenty-one cases

European Journal of Gynaecological Oncology

Volumn 19, Issue 2, 1998, Pages 182-185

  Saygili, U ^a   Uslu, T ^a   Erten, O ^a   Dogan E ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Borderline ovarian tumours; CA125; CA19.9; Mucinous; Serous

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; OVARY TUMOR; RETROSPECTIVE STUDY;

ASIA; BIOLOGY; DEVELOPING COUNTRIES; DISEASES; GENITALIA; GENITALIA, FEMALE; MEDITERRANEAN COUNTRIES; NEOPLASMS--WOMEN; OVARIAN EFFECTS; OVARY; PHYSIOLOGY; RESEARCH METHODOLOGY; RESEARCH REPORT; RETROSPECTIVE STUDIES; STUDIES; TURKEY; UROGENITAL SYSTEM; WESTERN ASIA; WOMEN;

ADENOCARCINOMA, MUCINOUS; ADULT; AGE DISTRIBUTION; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CYSTADENOCARCINOMA, PAPILLARY; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TURKEY;

EID: 0031942307     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Colgan T. J., Norris H. J.: "Ovarian epithelial tumours of low malignant potential: A review". Int. J. Gynecol. Pathol., 1983, 1, 367.
2. Snider D. D., Stuart G. C. E., Nation J. G. et al: "Evaluation of surgical staging in stage I low malignant potential ovarian tumours". Gynecol. Oncol., 1991, 40, 129.
3. Serov S. F., Scully R. E., Sobin L. H.: "International histological classification and staging of tumour No: 9 histologic typing of ovarian tumours" Geneva World Health Organization, 1973.
4. Harris R., Whittemore A. S. Intyre J.: "Collaborative ovarian cancer group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case control studied III. Epithelial tumours of low malignant potential in white women". Am. J. Epidemiol., 1992, 136, 1204.
5. Leake J. F., Currie J L., Rosenshein N. B. et al.: "Long term follow-up of serous tumours of low malignant potential". Gynecol. Oncol., 1992, 47, 150.
6. Chambers J. T., Merino M. J., Kohorn E. L. et al.: "Borderline ovarian tumours". Am. J. Obstet. Gynecol., 1988, 159, 1088.
7. Yazigi R., Sandstad J., Munoz A. K.: "Primary staging in ovarian tumours of low malignant potential". Gynecol. Oncol , 1988, 40, 402.
8. Shushan A., Palticl O., Iscovich J., Elchalal U., Peretz T., Schenker J. G.: "Human menopausal gonadotropin and the risk of epithelial ovarian cancer". Fertil, Steril, 1996, 65, 13.
9. Leake J. F: "Tumours of low malignant potential". Curi: Opin, Obstet, Gynecol., 1992, 4, 81.
10. Yoonessi M., Crickard K., Celik C. et al.: "Borderline epithelial tumours of the ovary: Ovarian intraepithelial neoplasia". Obstet. Gynecol. Surv., 1988, 43, 435.
11. Piura B., Dgani R., Blickstein et al.: "Epithelial ovarian tumours of borderline malignancy: A study of 50 cases". Int. J. Gynecol Cancer, 1992, 2, 189.
12. Tasker M., Langley F. A., "The outlook for women with borderline epithelial tumours of the ovary". Br. J. Obstet. Gynaecol., 1985, 93, 969.
13. Kliman L., Rome R. M., Fortune D. W.: "Low malignant potential tumours of the ovary: A study of 76 cases". Obstet. Gynecol., 1986, 68, 338.
14. Rose P. G., Rubin R. B., Beth E. N., Nelson B. E., Hunter R. E., Reale F. R.: "Accuracy of frozen section (intraoperative consultation) diagnosis of ovarian tumours". Am. J. Obstet. Gynecol., 1994, 171, 823.
15. Elchalal U., Dgani R., Piura B., Anteby O., Zalel Y. et al.: "Current concepts in management of epithelial ovarian tumours of low malignant potential". Obstet. Gynecol. Surv., 1994, 50, 62.
16. Sutton G. P., Bundy B. N., Omura G. A., Yordan E. L., Beecham J. S., Bonfiglio T.: "Stage II ovarian tumours of low malignant potential treated with cisplatin combination therapy (a gynecologic oncology group study)". Gynecol. Oncol., 1991, 41, 230.
17. Fort M. G., Pierce V K., Saigo P. E. Hoskins W. J., Lewis J. L.: "Evidence of the efficacy of adjuvant therapy in epithelial ovarian tumours of low malignant potential". Gynecol. Oncol., 1989, 32, 269.
18. Trimble C. L., Trimble E L.: "Management of epithelial ovarian tumours of low malignant potential". Gynecol. Oncol., 1994, 55, 52.
19. Burghardt E., Girardi F., Lahousen M. et al.: "Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer". Gynecol, Oncol., 1991, 40, 103.
20. Rice L. W., Lage J. M., Berkowitz R. S. et al.: "Preoperative serum CA125 levels in borderline tumours". Gynecol. Oncol., 1992, 46, 226.
21. Makar A. P., Kaern J., Kristansen G. B. et al.: "Evaluation of serum CA125 level as a tumor marker in the borderline tumours of the ovary". Int J. Gynecol Cancer, 1993, 3/5, 299.
22. [221 Bostwick D. G., Tazellar H. D., Ballon S. C. et al.: "Ovarian epithelial tumours of borderline malignancy. A clinical and pathologic study of 109 cases". Cancer, 1986, 58, 2052.